Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics - McDermott Will & Emery

Pasithea Therapeutics’ Acquisition of AlloMek Therapeutics

Overview


McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. The team was led by Robert Cohen and Eric Klee and included James Behrens, Mark Bilut, Cristell Fortune, Anisa Mohanty, Nick Paul, David Saunders, Michael Siekman, Jeronimo Soares de Sousa, Todd Solomon, Michelle Strowhiro, Kate Williams and Daniel Zucker.